🔗 Visit the ClinicalTrials.gov page for NCT02526017
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Combination cancer immunotherapies tailored to the tumour microenvironment. | Nat Rev Clin Oncol | 2015 | 1.54 |
| 2 | Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches. | Cancers (Basel) | 2015 | 0.90 |
| 3 | Immune checkpoint therapy for pancreatic cancer. | World J Gastroenterol | 2016 | 0.79 |
| 4 | Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium. | J Immunol Res | 2016 | 0.77 |
| 5 | Immunotherapy in glioblastoma: emerging options in precision medicine. | CNS Oncol | 2016 | 0.75 |
| 6 | Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer. | Oral Oncol | 2016 | 0.75 |